Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|January 11, 2024
Patent Foramen Ovale Percutaneous Closure: Evolution and Ongoing ChallengesPerrine Devos, Paul Guedeney, Gilles Montalescot, et al.
Water Research|February 13, 2023
Sidestream characteristics in water resource recovery facilities: A critical reviewPerrine Devos, Ahlem Filali, Paloma Grau, et al.
Therapie|December 13, 2021
From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicityStéphane Ederhy, Perrine Devos, Ariel Cohen, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 21, 2024
Levosimendan in Patients with Cardiogenic Shock Refractory to Dobutamine WeaningMichel Zeitouni, Elodie Dorvillius, David Sulman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 1, 2025
Pre-treatment with P2Y12 inhibitors in Acute Myocardial Infarction with Cardiogenic ShockAnthony Elhadad, David Sulman, Niki Procopi, et al.
Archives of Cardiovascular Diseases|August 17, 2024
Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohortDavid Sulman, Frederic Beaupré, Perrine Devos, et al.
Critical Care Medicine|May 26, 2026
Visual Right Ventricular Assessment in ICU: A Multicenter International StudyDavid Levy, Louise Boutrot, Matthieu Petit, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Efficacy and Safety of Intravenous Antiplatelet Therapy in Acute Myocardial Infarction With Cardiogenic ShockAnthony Elhadad, Omar El Zouhayri, Johanne Silvain, et al.
Revista Espanola De Cardiologia (English Ed.)|November 20, 2025
Prevalence of venous thromboembolic disease among patients with patent foramen ovale-related arterial ischemic eventsGabriel Chevrot, Gilles Montalescot, Schahrazed Larbi-Messaoud, et al.
Cancer Discovery|February 23, 2023
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor MyocarditisJoe-Elie Salem, Marie Bretagne, Baptiste Abbar, et al.
Pageof 1